2022 BOARD OF AMBASSADORS

CO-CHAIR

JACQUELINE GUICHELAAR

GROUP CIO

CISCO

Jacqueline Guichelaar joined Cisco in February 2019 as Senior Vice President and Group Chief Information Officer. She is spearheading the creation of a digital architecture to accelerate Cisco’s digital enterprise transformation.

She was named to the HITEC 100 for 2022, recognizing the 100 most influential Hispanic leaders. She received a 2021 Woman of Influence Award from the Silicon Valley Business Journal and was an honoree for the 2021 YWCA Golden Gate Silicon Valley Tribute to Women Award.

Guichelaar was additionally named to Fast Company’s Queer50 in 2020 and 2021, recognizing LGBTQ women and nonbinary innovators in business and technology.

 

 

CO-CHAIR

AUDREY FAUVEL

CHAIR

FENNECH FINANCIAL LTD

In Early 2017, after 20 years in the Financial Services Industry, she decided to create her own company specialising in Business Development and Talent Management. Audrey is involved in founding many Startups and is a Board Advisor, where she shares 20 years of successful Corporate experience.

VICE CHAIR

KELLY DUCOURTY

VP, GTM STRATEGY

GOOGLE

Currently serving as Vice President of GTM Strategy and Operations for Google Cloud, Kelly is responsible for developing and implementing their go-to-market strategy, from business operations and enablement to sales processes/tools.

Kelly has over 20 years’ experience leading field-facing teams, including time at HP(E) overseeing global accounts, specialist sales and pre-sales organizations. She has also worked in Service Delivery and IT transformation and has developed and scaled businesses across four continents.

Outside of Google, she serves as a Board Member for the British Benevolent Society in Northern California and is passionate about STEM+C education and career development for young women.

JENNIFER TEMPLE

EVP, CCO

HPE

Jennifer Temple joined the Hewlett Packard Enterprise leadership team as Chief Communications Officer in July 2018. She has devoted her career to advising chief executives and building high-performing teams to create customer loyalty, enact cultural change, and manage largescale transformations.

Faust, Jon0239.jpg

JON FAUST

HP GLOBAL CONTROLLER

HP INC.

Jon Faust was appointed Global Controller for HP Inc. in 2022. He has served as HP's Head of Finance Transformation & Corporate Services since joining HP in August 2021.

Prior to joining HP, he served as Chief Financial Officer of Aruba, a Hewlett Packard Enterprise Company, from February 2020 to July 2021, and before that he spent over 19 years at HPE in various roles including, among others, Senior Vice President and Chief Financial Officer - Hybrid IT (August 2018 to January 2020), Senior Vice President - Worldwide Financial Planning & Analysis and Global Functions Finance (April 2015 to July 2018), and Vice President and Chief Financial Officer - Technology & Operations (November 2013 to March 2015).

PACE LINCK

CLIENT ACCOUNT DIRECTOR

SALESFORCE

Harjott_closeup_2x_2x.png

HARJOTT ATRII

EVP

ZENSAR

Harjott is a digital business leader with over 24 years of experience, delivering success in the areas of IT- Business Alignment, Digital Transformation, AI, and Cloud, globally. A distinguished international board-level leader with strong commercial acumen, Harjott is accomplished in applying technology to achieve business results—shaping, planning, leading organizational transformation and performance improvement programs to drive technology-enabled business change at scale.
As Executive Vice President & Global Business Head of the Hitech, Manufacturing, Lifesciences and Smart cities business at Zensar, Harjott is responsible for leading and growing key portfolios including Hi-Tech, ISVs, Industrial, Process & Discrete Manufacturing sectors.

JOHN ORWIN

PRESIDENT & CEO

ATRECA

A biotechnology and pharmaceutical industry leader with over 25 years of experience, John Orwin, MBA, is President and CEO of Atreca, a biopharmaceutical company developing novel antibody-based cancer immunotherapeutics. Mr. Orwin is helping lead the charge in Atreca’s revolutionary and proprietary approach to oncology treatment, which has the potential to change the lives of large groups of patients.
His previous roles have included senior positions at biotechnology and pharmaceutical companies including Johnson & Johnson, Affymax, Rhone-Poulenc Rorer, Genentech (now a member of the Roche Group), and most recently Relypsa. During Mr. Orwin’s tenure at Relypsa, the company launched and commercialized its lead candidate, Patiromer (US brand name Veltassa®), and was acquired by Galenica (Vifor Pharma) in a transaction worth over $1.5 billion. Prior to Relypsa, he served as Chief Executive Officer and a member of the Board of Directors of Affymax. Previously, Mr. Orwin was Senior Vice President of the BioOncology Business Unit at Genentech, where he was responsible for all marketing, sales, business unit operations and pipeline brand management for Genentech’s oncology portfolio in the United States. He has also held senior marketing and sales positions at Johnson & Johnson, Alza Pharmaceuticals, Sangstat Medical Corporation, Rhône-Poulenc Rorer Pharmaceuticals and Schering-Plough Corporation.

ASIT GOEL

PARTNER

BAIN & COMPANY INC.

Asit Goel is a Leader in Bain’s Technology practice, and is based in our Silicon Valley office. He has deep industry experience in Internet of Things (wearables, smarthome, healthcare, industry 4.0) as well as in the semiconductors sector (strategy, product development, sales,  channel development, operations). Asit has 20+ years working in technology, with 10+ years at Bain. Prior to Bain he as SVP & GM for $600M+ IOT business at a large tech firm. Asit has a MBA from the Anderson School of Management, UCLA, and a B.E. from Bangalore Univ. (India).

JEAN-CLAUDE VIOLLIER

EVP, HEAD OF NORTH AMERICA WEST REGION

CAPGEMINI

As the Head of the NA West Region at Capgemini, Jean-Claude’s mission is to help his clients to get the future they want. Growth and transformation are his top priorities. Jean-Claude leads a world-class organization that understands clients’ long-term trajectories.
Before his current position, he has held various senior executive positions within Capgemini such as the Head of the High-Tech Market Unit, Chief Sales & Portfolio Officer for North America, Head of AppsOne Global Sales Office, Global Head of Channels and Partners as well as the Global Account Executive for Hewlett Packard (HP). He also managed High-Tech Manufacturing accounts for Capgemini in Europe from 1995 to 2000 before moving to the US in August 2000.

Dan Swisher_Jazz.jpg

DANIEL N. SWISHER JR.

PRESIDENT

JAZZ PHARMACEUTICALS

Daniel N. Swisher, Jr. was appointed Jazz’s president in January 2018. Mr. Swisher has extensive experience in the advancement and commercialization of novel therapeutics across multiple therapeutic areas including neuroscience, metabolic, and targeted cancer agents. As president, he oversees the commercial and operating businesses, as well as research and development, and global product strategy and commercial development. Throughout his career, Mr. Swisher has exhibited and encouraged global operational excellence to foster innovation.

JENNIFER BIRK

EVP, OPERATIONS

ORACLE

Jennifer Birk is Oracle’s executive vice president of operations. Her team is responsible for go-to-market planning and enablement as well as ensuring the sales force is aligned to support customers’ needs across Oracle and its broader ecosystem. Jennifer’s teams include sales operations, sales intelligence, field compensation, field enablement, Oracle Partner Network, Oracle Solution Centers, and mergers and acquisitions for sales. These groups work with teams across Oracle to ensure we’re aligned to connect the innovative products and services from our development organizations to our customers in the most efficient and effective means possible.

Jennifer joined Oracle in 2002 and has deep experience in transformation and operational excellence across the company. She began her Oracle career in finance, holding a variety of positions at headquarters and internationally. In this capacity, she built and managed several shared service centers in India and Romania, managed our internal systems, and drove operational improvements across the accounting and finance organizations. She returned to the US in 2009 and has since managed a number of operational functions, with a focus in revenue-generating organizations. Jennifer holds a degree in Business Honors and Accounting from the University of Texas. 

Jennifer Birk Pic 2.png.jpg
B Mclaughlin headshot.jpg

BRYAN MCLAUGHLIN

PARTNER

PwC

At his core, Bryan is a Silicon Valley based, technology finance professional who is strategic-minded and energized by the possible.  Over his 27-year tenure with PwC as a Capital Markets Advisory Partner with PwC, Bryan has advised and assisted many of the Firm’s premier clients in North America, Europe and the Middle East on more than 70 securities offerings, divestiture transactions and complex deal structures. Bryan currently serves as the PwC Global Relationship Partner for a Fortune 100, non-audit, and technology client of the firm.  In this role, Bryan leads a global team of partners and professionals who are committed to a vision and strategy that integrates and aligns PwC’s and his client’s goals and mission. 
Bryan is a loyal son of Boston College’s Carroll School of Management, holds an MBA with Merit from the Manchester Business School in the United Kingdom and maintains active CPA licenses in Massachusetts, New York and California. 

DR. SRIDHAR SESHADRI

CHIEF ADMINISTRATIVE OFFICER,

DESTINATION SERVICE LINES

STANFORD HEALTH CARE

Dr. Sridhar (“Sri”) Seshadri joined Stanford Health Care (SHC) in July 2003 and currently has oversight over the Cancer, Cardiovascular, Radiology, and Transplant programs. Dr. Seshadri also serves as the Co-Chair of the Funds Flow Workgroup that is responsible for the funds flow between the SHC and Stanford University’s School of Medicine (SOM).

Dr. Seshadri is a member of the Area Board of the American Cancer Society. He also serves on the Advisory Board of Stanford Medicine’s Artificial Intelligence in Medical Imaging (AIMI) Center.

Stanford_Seshadri%2C%20Sri_edited.jpg

HARSHUL ASNANI

SR. VP

& HEAD OF GLOBAL TECHNOLOGY BUSINESS

TECH MAHINDRA

As an integral part of the Tech Mahindra leadership team, Harshul is responsible for growth in the Hitech sector and the US West Coast. Harshul orchestrates a high performing global team focused on helping Hitech and enterprise customers traverse the transformation journey. In his current role, he also provides executive sponsorship to strategic 360-degree relationships with hyperscalers and other technology partners.
With a rich experience of over two decades  in the technology space, Harshul has been with Tech Mahindra for 7 years. Prior to his current role, Harshul was responsible for Tech Mahindra’s Communications business in North America where he grew the organization’s footprint from a nascent stage to a multi-hundred-million-dollar business in the region. 
As a seasoned tech professional, Harshul has served in various executive leadership roles which include P&L ownership, complex large IT/engineering outsourcing deals, strategic alliances, and ecosystem development at a global level.
Before Tech Mahindra, Harshul has worked in leadership roles with prestigious organizations like Wipro, HCL, Prodapt, Patni (now Capgemini) and Compaq (now HP)